Shaniah Leduc has been Chair of the Board of Directors at Breast Cancer Canada since 2022 after first joining the board in 2018. Shaniah’s tenure marks a pivotal era for the organization showcasing her leadership acumen through stakeholder collaboration and strides in scientific advancement.

As the President of Cancer Insights, Shaniah’s impact resonates across the medical landscape. With close to 30 years of oncology experience in clinical research, as a scientific advisor and health care consultant, Shaniah’s commitment to oncology is unwavering. Shaniah’s adept fusion of clinical, academic, and industry expertise has influenced research paradigms, emphasizing the significance of targeted and individualized approaches through precision oncology.

Under Shaniah’s dynamic governance, Breast Cancer Canada continues to expand its impact, propelling the organization into the forefront of the breast cancer landscape with a broader scope of research and education initiatives.

Shaniah’s influence extends beyond the Canadian borders, as evidenced by her pivotal roles on international advisory boards and collaborative work with the World Health Organization (WHO). Her passion for expanding medical treatment and diagnostic standards has positioned her as a champion in advancing precision oncology solutions in efforts to offer better care to breast cancer patients. In her relentless pursuit, Shaniah has become a sought after expert and advocate, elevating Breast Cancer Canada to new heights under her transformative leadership.